ICIBS Trial - Improving Patient Information About Bowel Cancer Screening - a Decision Aid Trial
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00148226|
Recruitment Status : Completed
First Posted : September 7, 2005
Last Update Posted : January 4, 2006
This project has been completed and consisted of a randomised trial of six tailored decision aids giving patients evidence-based information about faecal occult blood test screening for bowel cancer. 314 Australians aged between 50-74 years were recruited from five general practices and randomised to received either the tailored decision aid with age-gender and family history specific information and values clarification exercise or a standard government information sheet.
The decision aid significantly increased the proportion of people who were informed participants in the screening program.
|Condition or disease||Intervention/treatment||Phase|
|Colorectal Cancer Screening||Behavioral: Decision Aid||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Intervention Model:||Parallel Assignment|
|Official Title:||Randomized Controlled Trial of Patient Decision Aids for Faecal Occult Blood Test Screening|
|Study Start Date :||November 2003|
|Study Completion Date :||September 2005|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00148226
|Australia, New South Wales|
|University of Sydney|
|Sydney, New South Wales, Australia, 2006|
|Principal Investigator:||Lyndal J Trevena, MBBS||University of Sydney|
|Study Director:||Les Irwig, PhD||University of Sydney|